|
|
|
Six months in, the Pfizer-BioNTech vaccine is still effective. |
A company study of 46,000 participants showed that volunteers receiving the Pfizer-BioNTech vaccine remained more than 90% protected against symptomatic COVID-19 and were even better protected against severe disease six months after receiving the second dose. The vaccine is effective against virus variant B.1.351, first identified in South Africa, the company said. |
The study did not reveal any serious safety concerns among 12,000 volunteers receiving the vaccine. |
It's Thursday, and this is Coronavirus Watch from the USA TODAY Network. Here's more news to know today, as of 1:30 p.m. EDT: |
|
Vaccine tracker: Here's where to check in on how vaccine distribution is going in your state and across the country. |
Thanks for subscribing to Coronavirus Watch. Know someone looking for daily news updates right in their inbox? Forward this email along so they can sign up right here. |
– Jay Cannon, USA TODAY Network, Wires Editor; @JayTCannon on Twitter |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|